Pharmaceutical Care Network Europe

The Pharmaceutical Care Network Europe (PCNE) was established in 1994 by a number of European pharmaceutical care researchers. It became an official association (under Dutch law) in 2004.

Medication Review Drug-related problem classification Guidelines and Indicators

PCNE Medication Review Symposium 2012, Leuven, Belgium

29 May 2012


IMG 1898 1

 

The Pharmaceutical Care Network Europe strongly believes that in order to develop high quality research, you need to continually update yourself, and exchange expertise and experience with colleagues in the same research field. Workshops and working conferences are organised in that context.

On the 29th May 2012, a symposium was organised by the Pharmaceutical Care Network Europe at the Katholic University of Leuven. Researchers from Europe and USA contributed to the concepts behind medication review and brought new viewpoints.

PCNE would like to thank the Departments of Pharmacy of the KU Leuven, the Algemeen Pharmaceutiasche Bond en the Brabantse Apotheker Forum for their their much appreciated support

 

Downloads:

See the other tab for the abstracts and presentations or the workshop reports.

Lecture presentations

(Click on underlined word for download)

  • Polymedication-Check – study design for a randomised controlled trial in community pharmacies. Markus Messerli, Switzerland
  • Integrated pharmaceutical care in the Netherlands. Prof. Dr. Han de Gier, the Netherlands
  • The New Medicine Service: A new initiative to support patients with their medicines. Dr. Matthew Boyd, Ms. Katharine Wells, United Kingdom
  • Personal pharmacist – medical review in pharmaceutical care process. Dr. Arijana Mestrovic, Croatia
  • Medication Review in the US and Australia, Dr. Saija Leikola,  Finland
  • PHARM-HF - Pharmacist and Physician Care for Patients with Chronic Heart Failure.  Dr. Nina Griese, Germany.

Workshop reports

(Click on underlined word for download, pdf opens in new window)

I. Patient selection criteria for medication review

(Facilitators: Foppe van Mil and Charlotte Rossing)
How should we select patients and prioritise patients who need a medication review? Based on risk for medication problem, based on (potential) diseases, based on age – living circumstances or combinations of such criteria.
Aim: Develop patient selection criteria for inclusion in a medication review standard

II. Collecting all available information about patients drugs and diseases

(Facilitators: Ariana Mestrovic and Saija Leikola)
Through GPs, nurses and/or other health care professionals, or should we use electronic patient dossiers. How about a brown bag method/ Home visits incl. specific questions. Is it possible to develop international interview guidelines?
Aim: Develop schemes for an inventory of drugs used and diseases suffered, applicable under different circumstances.

III How to perform a medication review (Facilitators: Nina Griese and Veerle Foulon)

What are the different existing methods and what is the role of treatment standards and (inter)national differences. Are alternative approaches useful, e.g. focus on most frequently occurring problems. And what is the role of prescribing and/or dispensing software?
Aim: Develop a standard for the process of medication review that is internationally applicable.